Infrared FluorescenceDoes near-infrared fluorescent cholangiography with indocyanine green reduce bile duct injuries and conversions to open surgery during laparoscopic or robotic cholecystectomy? — A meta-analysis
Introduction
Laparoscopic cholecystectomies (LC) are among the most common surgical procedures performed worldwide, accounting for between 600,000 and 900,000 procedures annually in the United States alone.1,2 Starting in the mid-1980s, a shift from open to laparoscopic cholecystectomies (LC) occurred, for reasons that included markedly less scarring, shortened hospital stays and recovery times, and reduced operative times and costs.3 This transition has not been without problems; however, as bile duct injuries (BDI), the number one concern of surgeons performing LC,4, 5, 6 appeared to increase in frequency with the emergence of LC, from 1 to 2 BDI per 1,000 procedures7 to as many as 1 per 100.8, 9, 10, 11, 12 This increased incidence has persisted over time,13,14 despite the adoption of imaging techniques such as intraoperative cholangiography (IOC) and ultrasound. Such BDI may significantly prolong hospital stays, increase the need for further surgery, markedly elevate hospital costs, and result in chronic morbidity and significantly increased mortality.15, 16, 17 Many BDI patients experience reduced quality of life for years,18, 19, 20 and roughly 4% of BDI patients had premature mortality directly attributed to their BDI.21,22
Another problem that arises during LC is the need for conversion from laparoscopic to open surgery, which occurs in an estimated 6.2% of patients.23 Such conversion also markedly increases patient morbidity and mortality, duration of hospital stay and convalescence, and healthcare costs.24,25 In a 151-study meta-analysis published by Pucher et al in 2018,23 which included randomized clinical trials (RCT) and prospective and retrospective nonrandomized comparative and observational studies, overall encompassing over 500,000 patients, the pooled rate for BDI was 0.52%, or 52 per 10,000. In this same meta-analysis, the pooled rate for conversions from laparoscopic to open surgery was 620 per 10,000.
Studies have shown that the main cause of BDI and conversions to open surgery in patients undergoing LC is inadequate visualization of essential extra-hepatic biliary structures, such as the cystic duct.26, 27, 28 During the past decade, new technology has emerged to facilitate the visualization of such structures, via the preoperative intravenous injection of indocyanine green (ICG), followed by the intraoperative use of near-infrared fluorescence imaging, a combined process called near-infrared fluorescent cholangiography (NIFC). In a recently published RCT that compared 321 laparoscopic cholecystectomy procedures during which NIFC was used against 318 procedures during which it was not, NIFC dramatically increased predissection visualization rates for all 7 extra-hepatic biliary structures that were assessed: cystic duct, right hepatic duct, common hepatic duct, common bile duct, cystic CBD junction, cystic gallbladder junction, and accessory ducts, with strongly statistically significant odds ratios ranging from 2.3 to 3.6.29 Five of these 7 structures also were statistically more often visible postdissection, with odds ratios ranging from 2.4 to 3.3. To date, this just-mentioned study is the only published RCT comparing NIFC versus standard white light during LC. Although there were 2 BDI in the control group and none in the NIFC group, and 4 conversions in the control group versus 1 in the NIFC group, the study lacked the statistical power for these to be statistically significant differences (P = .25 and 0.17, respectively). In fact, assuming a 0.4% BDI event rate23 and a 1:1 ratio of cases and controls, even detecting a 50% decrease between groups with 95% confidence and 80% power would require a study with almost 12,000 patients per treatment arm.30 With an assumed 5.0% event rate for conversions to open surgery, such a study would require over 2,000 patients per group.
The primary purpose of this article is to report the results of a systematic literature review and meta-analysis conducted to compare both BDI and conversion-to-open–surgery rates in patients undergoing minimally invasive cholecystectomy with versus without NIFC. Given the recent steady rise in the percentage of cholecystectomy procedures being performed robotically (albeit still only accounting for under 10% of all cholecystectomies),31 a decision was made to include both laparoscopic cholecystectomy (LC) and robotic cholecystectomy (RC) studies in the analysis. Secondary purposes were to compare the effects of NIFC on BDI and open conversion rates in LC and RC individually and evaluate all studies for the risk of bias.
A thorough search of the medical literature was conducted to identify all studies, published in full print or open access form, for which the incidence of BDI or open conversion was reported, assessing the effectiveness of NIFC during LC; and in which NIFC was not used during LC.
To be eligible for analysis, articles had to meet the following eligibility criteria: (1) report absolute numbers of patients who had undergone LC or RC, either with or without the use of NIFC; (2) either report on the absolute number of BDI or conversions to open surgery or provide percentages to at least 1 decimal place, so those absolute numbers could be accurately calculated; (3) be published from 2013 onward because the only NIFC studies we were able to identify were from 2013 onward; (4) have virtually all data collected from 2010 onward, to similarly reduce the use of old data published late; (5) have study cohorts consisting of at least 100 patients either receiving or not receiving NIFC, to reduce the risk of positive publication bias; (6) be available in print or full open-access form, so a full risk of bias assessment could be performed; (7) be deemed at low to, at most, moderate risk of bias, specifically related to the rate of BDI and conversions to open surgery (thereby, not concerned with the level of bias for other outcomes); and (8) not include patients with cholelithiasis, biliary atresia, or cancer as the indication for surgery. Non-English articles only were excluded if they could not be translated or otherwise interpreted by at least one of the authors.
The identification of relevant studies was conducted in 2 stages. In stage 1, a PubMed search was conducted, from April through October 2020, looking for relevant search terms, from which all abstracts were reviewed, seemingly pertinent articles read to completion, and final eligibility determined. In stage 2, all tables and bibliographies listing other pertinent studies in read articles were reviewed to identify additional articles that might be eligible for inclusion, then these articles read to determine their eligibility.
For NIFC studies, we used the following combined search terms: “fluorescence” and “cholecystectomy” (n = 128 abstracts); “indocyanine green” and “cholecystectomy” (n = 114); “robotic” and “cholecystectomy” (n = 407); “indocyanine green” and “bile duct injury” (n = 30); and “indocyanine green” and “conversion” (n = 173; total n = 852; Fig 1). For non-NIFC studies, the combined search terms used were “cholecystectomy” and “bile duct injury” (n = 1,253); “cholecystectomy” and “conversion” (n = 2,478), and “cholecystectomy” and “robotic” (n = 407; total n = 4,138). To be eligible for inclusion, studies had to also report the absolute numbers of BDI or conversions to open surgery and the number of patients treated by LC. When studies also included patients who underwent open surgery, the number of patients who had their surgery performed laparoscopically or robotically and number of BDI or conversions specifically among those patients had to be reported, accompanied by approach-specific outcomes.
Variables of interest were first author name; year of article publication; period of data collection, country where the study was conducted; surgical approach (LC versus RC); study design, objectives, and treatment arms; number of patients in each treatment arm; treatments rendered; and absolute number of BDI and conversions to open surgery.
Each study was assessed for bias risk using either the Cochrane Risk of Bias tool32 for RCTs and quasi-randomized trials or the Cochrane ROBINS I tool33 for non-RCTs. Using the Cochrane Risk of Bias tool,32 each RCT was evaluated for the 6 of 8 potential sources of bias deemed relevant (excluding mortality and long-term outcomes): random sequence generation and allocation concealment (both for selection bias), blinding of patients and personnel (performance bias), blinding of outcome assessments (detection bias), completeness of short-term data (attrition bias), and selective reporting (selection bias). Using the Cochrane ROBINS I tool,33 studies were assessed for potential confounding, subject selection, intervention classification, unintended differences and contamination between treatment arms, missing data, measurement bias, and selective reporting. The risk of bias for each study was rated as very low, low, moderate, or high, specifically pertaining to the determination of BDI and conversion-to-open–surgery rates, as follows: very low, if the study was judged at low risk across all domains; low, if no more than one domain was judged at moderate risk, and no domain at high risk; moderate, if judged to be at moderate risk in more than one domain, but at high risk in none; high, if any domain was considered at high risk. Domains for which data were not clearly reported were automatically deemed a source of moderate risk. Studies considered at high risk were excluded from additional analysis.
The 2 primary outcomes of interest were the incidence of BDI and incidence of conversions to open surgery, each expressed as the number of events per 10,000 patients, weighted for the number of subjects per study. Unweighted rates also were calculated, by averaging incidence rates over all studies, to adjust for large variations in study size. To account for acute cholecystitis, the number of patients who underwent LC or RC for acute cholecystitis was extracted from each study to allow for calculation of the overall percentage of acute cholecystitis patients in each of the 2 patient cohorts (NIFC versus non-NIFC), after which BDI and open-conversion rate estimates were multiplied by a product of this percentage difference and the estimated difference in BDI or conversion rate from other studies (outside the current analysis) restricted to acute cholecystitis patients. To account for potential differences between LC and RC, rates for BDI and open conversions were estimated combining LC and RC patients, and with LC and RC patients analyzed separately, after which weighted estimates were generated using the same method described above for acute cholecystitis.
Forest plots of the weighted data were generated for BDI and conversions for each of 3 comparisons: (1) all patients, LC and RC, who underwent LC with NIFC versus no NIFC; (2) NIFC versus non-NIFC just among LC patients; and (3) NIFC versus non-NIFC just among RC patients.
Section snippets
NIFC studies (N = 5)
Among the 852 abstracts reviewed specifically searching for studies on the use of NIFC during LC or RC, there was considerable overlap (n = 317; Fig 1). Ultimately, 46 articles deemed relevant, on the basis of having patients who underwent LC or RC for whom BDI or open conversion data were available, were identified, with 3 additional articles located via a reference list, ultimately yielding 49 articles for additional review. Of these, 44 failed to meet the criterion of at least 100 subjects
Discussion
Near-infrared fluorescent cholangiography is increasingly emerging as an intraoperative imaging modality to enhance outcomes and reduce complications across a wide range of surgical specialties, with a rapidly expanding body of evidence, including numerous recently published meta-analyses and systematic reviews, documenting its effectiveness facilitating the evaluation of tissue perfusion71, 72, 73, 74, 75; detection and prediction of anastomotic leaks72,76, 77, 78, 79; localization and
Funding/Support
This study received no funding from any external source.
Conflict of interest/Disclosure
The authors of this article have no conflicts of interest to disclose.
References (117)
- et al.
Complications after laparoscopic cholecystectomy
Am J Surg
(1993) - et al.
The heavy price of conversion from laparoscopic to open procedures for emergent cholecystectomies
Am J Surg
(2019) - et al.
Laparoscopic cholecystectomy: what is the price of conversion?
Surgery
(2012) - et al.
Rationale and use of the critical view of safety in laparoscopic cholecystectomy
J Am Coll Surg
(2010) - et al.
National trends and outcomes of inpatient robotic-assisted versus laparoscopic cholecystectomy
Surgery
(2020) - et al.
Management of acute cholecystitis in the laparoscopic era: results of a prospective, randomized clinical trial
J Gastrointest Surg
(2003) - et al.
The role of intraoperative fluorescence imaging during esophagectomy
Thorac Surg Clin
(2018) - et al.
A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping
Eur J Surg Oncol
(2016) - et al.
Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis
Am J Obstet Gynecol
(2017) - et al.
Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies
World J Surg Oncol
(2017)
Gallbladder, Cholecystectomy, Laparoscopic. StatPearls. Treasure
Regional cost analysis for laparoscopic cholecystectomy
Surg Endosc
Laparoscopic cholecystectomy versus mini-laparotomy cholecystectomy: a prospective, randomized, single-blind study
Ann Surg
Early management of operative injuries of the extrahepatic biliary tract
Ann Surg
Iatrogenic bile duct injuries: avoidance, recognition, and treatment
Mil Med
Bile duct injuries during laparoscopic cholecystectomy
Surg Endosc
Routine use of fluorescent incisionless cholangiography as a new imaging modality during laparoscopic cholecystectomy
Surg Endosc
Laparoscopic cholecystectomy: first, do no harm; second, take care of bile duct stones
Surg Endosc
An analysis of the problem of biliary injury during laparoscopic cholecystectomy
J Am Coll Surg
Bile Duct, Repair. StatPearls. Treasure Island (FL)
Bile duct injury during laparoscopic and conventional cholecystectomy
J Am Coll Surg
Biliary tract complications in laparoscopic cholecystectomy. A multicenter study of 148 biliary tract injuries in 26,440 operations
Surg Endosc
Less surgical experience has no impact on mortality and morbidity after laparoscopic cholecystectomy: a prospective cohort analysis
Surg Laparosc Endosc Percutan Tech
Long-term outcomes of patients with common bile duct injury following laparoscopic cholecystectomy
Surg Endosc
A cost analysis of operative repair of major laparoscopic bile duct injuries
S Afr Med J
Long-term impact of iatrogenic bile duct injury
Dig Surg
Impaired quality of life 5 years after bile duct injury during laparoscopic cholecystectomy: a prospective analysis
Ann Surg
Impact of bile duct injury after laparoscopic cholecystectomy on quality of life: a longitudinal study after multidisciplinary treatment
Endoscopy
Claims for damages as a result of bile-duct injury during (laparoscopic) cholecystectomy
Ned Tijdschr Geneeskd
Long-term impact of bile duct injury on morbidity, mortality, quality of life, and work related limitations
Ann Surg
Effect of intended intraoperative cholangiography and early detection of bile duct injury on survival after cholecystectomy: population based cohort study
BMJ
Outcome trends and safety measures after 30 years of laparoscopic cholecystectomy: a systematic review and pooled data analysis
Surg Endosc
Causes and prevention of laparoscopic bile duct injuries: analysis of 252 cases from a human factors and cognitive psychology perspective
Ann Surg
A safe laparoscopic cholecystectomy depends upon the establishment of a critical view of safety
Surg Today
Randomized trial of near-infrared incisionless fluorescent cholangiography
Ann Surg
Comparing Two Proportions: Sample Size 2020
Chapter 8: Assessing risk of bias in included studies
In: Cochrane Handbook for Systematic Reviews of Interventions
ROBINS-I: a tool for assessing risk of bias in non−randomised studies of interventions
BMJ
Risk factors for open conversion in minimally invasive cholecystectomy
JSLS
Fluorescence-based cholangiography: preliminary results from the IHU-IRCAD-EAES EURO-FIGS registry
Surg Endosc
Fluorescent cholangiography in laparoscopic cholecystectomy: an updated Canadian experience
Surg Innov
Indocyanine green (ICG) fluorescent cholangiography during robotic cholecystectomy: results of 184 consecutive cases in a single institution
Surg Innov
Outcomes of laparoscopic cholecystectomy done with surgical energy versus done without surgical energy: a prospective-randomized control study
Surg Endosc
Single-site robotic cholecystectomy at an inner-city academic center
JSLS
Single-incision cholecystectomy: a comparative study of standard laparoscopic, robotic, and SPIDER platforms
Surg Endosc
Single-incision laparoscopic cholecystectomy using instrumental alignment in robotic single-site cholecystectomy
Ann Surg Treat Res
Urgent and elective robotic single-site cholecystectomy: analysis and learning curve of 150 consecutive cases
J Laparoendosc Adv Surg Tech A
A large-cohort comparison between single incision laparoscopic cholecystectomy and conventional laparoscopic cholecystectomy from a single center; 2080 cases
Ann Hepatobiliary Pancreat Surg
Operative outcome and patient satisfaction in early and delayed laparoscopic cholecystectomy for acute cholecystitis
Minim Invasive Surg
A retrospective comparison of robotic cholecystectomy versus laparoscopic cholecystectomy: operative outcomes and cost analysis
Surg Endosc
Cited by (36)
Acute cholecystitis: Which flow-chart for the most appropriate management?
2023, Digestive and Liver DiseaseReal-time indocyanine green fluorescence technique reduces anastomotic leakage in bilioenteric anastomosis: A case report and literature review
2023, Photodiagnosis and Photodynamic TherapyIndocyanine green (ICG) fluorescent cholangiography in laparoscopic cholecystectomy: Simplifying time and dose
2023, Digestive and Liver DiseaseCitation Excerpt :This study, however, was not able to demonstrate a lower rate of bile duct injuries; possibly motivated by the large number of patients needed to be included in each study arm to achieve statistical significance [14]. A recent meta-analysis suggests that the incidence of bile duct injury may decrease with the use of ICG [15], but despite the lack of definitive evidence, it seems only logical to think that ICG is a great tool to add to the surgeon's armamentarium in order to perform safer cholecystectomies, as most of the injuries occur due to anatomy misinterpretation. The consensus guide for the use of the ICG in HPB surgery has recently been published [16] and in the fluorescence cholangiography section it is concluded with a level of evidence I, that ICG can facilitate the identification of the bile duct and its possible anatomical variations while helping to perform a safe dissection of the structures.
Management of complex acute biliary disease for the general surgeon: A narrative review
2023, American Journal of SurgeryIntraoperative fluorescence imaging in different surgical fields: First step to consensus guidelines
2022, Surgery (United States)Intraoperative fluorescence imaging in different surgical fields: Consensus among 140 intercontinental experts
2022, Surgery (United States)Citation Excerpt :Surgeons performing laparoscopic cholecystectomies, along with colorectal and lymphedema surgeons, also said that FI should be routinely performed (among colorectal surgeons, consensus was reached only for its routine use with left-sided anastomoses), whereas selective use was the choice of surgeons performing gastric cancer SLN mapping, plastic surgery, postanastomosis proctosigmoidoscopy, or thyroid and parathyroid resections. The confidence of cholecystectomy surgeons in FI seems well founded, supported by both a large (N = 639) international randomized clinical trial (RCT)11 and a meta-analysis of 16 studies (5 using near-infrared fluorescence cholangiography with ICG and 11 not (n = 5,070).12 In the RCT, which compared 321 patients who underwent laparoscopic cholecystectomy with near-infrared fluorescence cholangiography against 318 in whom it was not used, the visualization of biliary structures deemed essential to performing the procedure and preventing complications was 2.3- to 3.6-fold as high in the former group; anatomical visualization also was much less affected by obesity and surgical field inflammation.11